Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth K W To

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 2, 2020
In vivo biocompatibility and efficacy of dexamethasone-loaded PLGA-PEG-PLGA thermogel in an alkali-burn induced corneal neovascularization disease modelPui S Chan, Qingqing Li, Bowen Zhang, et al.
British Journal of Pharmacology|May 20, 2015
Pelitinib (EKB-569) targets the up-regulation of ABCB1 and ABCG2 induced by hyperthermia to eradicate lung cancerKenneth K W To, Daniel C Poon, Yuming Wei, et al.
The EMBO Journal|October 7, 2006
The phosphorylation status of PAS-B distinguishes HIF-1alpha from HIF-2alpha in NBS1 repressionKenneth K-W To, Olga A Sedelnikova, Melissa Samons, et al.
ACS Pharmacology & Translational Science|October 19, 2023
Circumvention of Gefitinib Resistance by Repurposing Flunarizine via Histone Deacetylase InhibitionKenneth K W To, James C H Chow, Ka-Man Cheung, et al.
Data in Brief|March 26, 2016
Data showing the circumvention of oxaliplatin resistance by vatalanib in colon cancerKenneth K W To, Daniel C Poon, Yuming Wei, et al.
International Journal of Antimicrobial Agents|February 14, 2026
Treatment sequences of a phage and colistin combination trigger different evolution pathways of a multidrug-resistant Acinetobacter baumannii yielding distinct treatment outcomesSubhankar Mukhopadhyay, Xiaoxu Zhang, Kenneth K W To, et al.
International Journal of Antimicrobial Agents|August 13, 2023
Sequential treatment effects on phage-antibiotic synergistic application against multi-drug-resistant Acinetobacter baumanniiSubhankar Mukhopadhyay, Pengfei Zhang, Kenneth K W To, et al.
Biochemical Pharmacology|November 7, 2016
Effect of abemaciclib (LY2835219) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivoTong Wu, Zhen Chen, Kenneth K W To, et al.
Molecular Cancer Therapeutics|October 15, 2009
Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2Kenneth K W To, Robert W Robey, Turid Knutsen, et al.
Biochemical Pharmacology|July 25, 2015
Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxiaKenneth K W To, Daniel C Poon, Yuming Wei, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 2, 2020
In vivo biocompatibility and efficacy of dexamethasone-loaded PLGA-PEG-PLGA thermogel in an alkali-burn induced corneal neovascularization disease modelPui S Chan, Qingqing Li, Bowen Zhang, et al.
British Journal of Pharmacology|May 20, 2015
Pelitinib (EKB-569) targets the up-regulation of ABCB1 and ABCG2 induced by hyperthermia to eradicate lung cancerKenneth K W To, Daniel C Poon, Yuming Wei, et al.
The EMBO Journal|October 7, 2006
The phosphorylation status of PAS-B distinguishes HIF-1alpha from HIF-2alpha in NBS1 repressionKenneth K-W To, Olga A Sedelnikova, Melissa Samons, et al.
ACS Pharmacology & Translational Science|October 19, 2023
Circumvention of Gefitinib Resistance by Repurposing Flunarizine via Histone Deacetylase InhibitionKenneth K W To, James C H Chow, Ka-Man Cheung, et al.
Data in Brief|March 26, 2016
Data showing the circumvention of oxaliplatin resistance by vatalanib in colon cancerKenneth K W To, Daniel C Poon, Yuming Wei, et al.
International Journal of Antimicrobial Agents|February 14, 2026
Treatment sequences of a phage and colistin combination trigger different evolution pathways of a multidrug-resistant Acinetobacter baumannii yielding distinct treatment outcomesSubhankar Mukhopadhyay, Xiaoxu Zhang, Kenneth K W To, et al.
International Journal of Antimicrobial Agents|August 13, 2023
Sequential treatment effects on phage-antibiotic synergistic application against multi-drug-resistant Acinetobacter baumanniiSubhankar Mukhopadhyay, Pengfei Zhang, Kenneth K W To, et al.
Biochemical Pharmacology|November 7, 2016
Effect of abemaciclib (LY2835219) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivoTong Wu, Zhen Chen, Kenneth K W To, et al.
Molecular Cancer Therapeutics|October 15, 2009
Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2Kenneth K W To, Robert W Robey, Turid Knutsen, et al.
Biochemical Pharmacology|July 25, 2015
Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxiaKenneth K W To, Daniel C Poon, Yuming Wei, et al.
Pageof 10